Xiaohong Hao

842 total citations
11 papers, 736 citations indexed

About

Xiaohong Hao is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Xiaohong Hao has authored 11 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomedical Engineering, 5 papers in Molecular Biology and 4 papers in Biomaterials. Recurrent topics in Xiaohong Hao's work include Bone Tissue Engineering Materials (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Bone Metabolism and Diseases (3 papers). Xiaohong Hao is often cited by papers focused on Bone Tissue Engineering Materials (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Bone Metabolism and Diseases (3 papers). Xiaohong Hao collaborates with scholars based in China and United States. Xiaohong Hao's co-authors include Xing‐Jie Liang, Jinchao Zhang, Xixue Hu, Guozhang Zou, Guang Jia, Shizhu Chen, Dandan Liu, Juan Liu, Yan Wu and Kun Ge and has published in prestigious journals such as Advanced Materials, ACS Nano and Nanoscale.

In The Last Decade

Xiaohong Hao

11 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaohong Hao China	9	417	326	280	176	66	11	736
Saipeng Huang China	17	224 0.5×	357 1.1×	184 0.7×	193 1.1×	96 1.5×	46	809
Jiaojun Wei China	17	502 1.2×	160 0.5×	272 1.0×	231 1.3×	55 0.8×	26	883
Miguel Gisbert-Garzarán Spain	12	321 0.8×	221 0.7×	298 1.1×	162 0.9×	30 0.5×	17	638
Diti Desai Finland	17	328 0.8×	213 0.7×	290 1.0×	226 1.3×	26 0.4×	28	796
Qiaoli Wu China	11	264 0.6×	311 1.0×	305 1.1×	225 1.3×	40 0.6×	17	857
Haoqi Tan China	15	253 0.6×	180 0.6×	199 0.7×	151 0.9×	95 1.4×	22	807
Andrey S. Drozdov Russia	16	288 0.7×	188 0.6×	219 0.8×	130 0.7×	25 0.4×	39	690
Danzhu Zhu China	15	341 0.8×	315 1.0×	207 0.7×	273 1.6×	36 0.5×	24	811
N. Vijayakameswara Rao Taiwan	17	466 1.1×	251 0.8×	344 1.2×	293 1.7×	20 0.3×	33	927
Riku Kawasaki Japan	14	200 0.5×	230 0.7×	165 0.6×	185 1.1×	44 0.7×	56	615

Countries citing papers authored by Xiaohong Hao

Since Specialization

Citations

This map shows the geographic impact of Xiaohong Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Hao more than expected).

Fields of papers citing papers by Xiaohong Hao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Hao. The network helps show where Xiaohong Hao may publish in the future.

Co-authorship network of co-authors of Xiaohong Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Hao. A scholar is included among the top collaborators of Xiaohong Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Hao. Xiaohong Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Hao, Xiaohong, et al.. (2019). Shikonin potentiates paclitaxel antitumor efficacy in esophageal cancer cells via the apoptotic pathway. Oncology Letters. 18(3). 3195–3201. 14 indexed citations

Lv, Hongyan, Su Zhang, & Xiaohong Hao. (2019). Swainsonine protects H9c2 cells against lipopolysaccharide-induced apoptosis and inflammatory injury via down-regulating miR-429. Cell Cycle. 19(2). 207–217. 9 indexed citations

Hao, Xiaohong, Xixue Hu, Cuimiao Zhang, et al.. (2015). Hybrid Mesoporous Silica-Based Drug Carrier Nanostructures with Improved Degradability by Hydroxyapatite. ACS Nano. 9(10). 9614–9625. 196 indexed citations

Chen, Shizhu, Xiaohong Hao, Xing‐Jie Liang, et al.. (2015). Inorganic Nanomaterials as Carriers for Drug Delivery. Journal of Biomedical Nanotechnology. 12(1). 1–27. 112 indexed citations

Xue, Xiangdong, Yuanyuan Zhao, Luru Dai, et al.. (2013). Spatiotemporal Drug Release Visualized through a Drug Delivery System with Tunable Aggregation‐Induced Emission. Advanced Materials. 26(5). 712–717. 192 indexed citations

Hao, Xiaohong, et al.. (2013). Recent Advances of Mesoporous Silica Based Multifunctional Nano Drug Delivery Systems. ACTA AGRONOMICA SINICA. 40(10). 1014–1014. 2 indexed citations

Hu, Xixue, Xiaohong Hao, Yan Wu, et al.. (2012). Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dual response. Journal of Materials Chemistry B. 1(8). 1109–1109. 125 indexed citations

Cao, Weipeng, Xiaohong Hao, Xue Xue, et al.. (2012). Metallofullerene nanoparticles promote osteogenic differentiation of bone marrow stromal cells through BMP signaling pathway. Nanoscale. 5(3). 1205–1205. 52 indexed citations

Zhang, Jinchao, Jing Sun, Xiaohong Hao, et al.. (2012). Effects of La3+ on osteogenic and adipogenic differentiation of primary mouse bone marrow stromal cells. Journal of Rare Earths. 30(1). 90–93. 21 indexed citations

10.

Zhang, Jinchao, Yaping Li, Qun Zhang, Xiaohong Hao, & Shuxiang Wang. (2012). Effects of gadolinium on proliferation, differentiation and calcification of primary mouse osteoblasts in vitro. Journal of Rare Earths. 30(8). 831–834. 8 indexed citations

11.

Zhang, Jinchao, et al.. (2011). Effects of Er3+ on the proliferation, differentiation and mineralization function of primary mouse osteoblasts in vitro. Journal of Rare Earths. 29(5). 507–510. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact